レポートナンバー 0000033212
性感染症（STD）治療の世界市場（2022-2026）
TechNavio
Global Sexually Transmitted Diseases (STD) Treatment Market 2022-2026
発刊日
2022/09/02
言語英語
体裁PDF/120ページ
レポート概要
本レポートは、性感染症（STD）治療市場を分析します。
世界の性感染症（STD）治療市場は、予測期間中に約4.27 %のCAGRで推移し、2022年から2026年の間に134億8,000万USドルの成長が見込まれています。本レポートは、総体的な分析、市場規模と予測、動向、成長推進要因、課題、および約25社のベンダーを対象とするベンダー分析を提供しています。
本レポートは、現在の世界市場シナリオ、最新動向と成長推進要因、および全体的な市場環境に関する最新の分析を提供します。市場は、STDの有病率の増加、有利な償還政策の存在、世界各国の政府によるイニシアチブの増加によって牽引されています。
調査範囲
-
市場セグメント
➣ タイプ別
◇ ウイルス感染症
◇ 細菌感染症
◇ その他の感染症
➣ 地域別
◇ 北アメリカ
◇ アジア
◇ ヨーロッパ
◇ その他の地域
本調査では、STDの迅速な診断の進歩が、今後数年間の性感染症（STD）治療市場の成長を促進する主要な理由の1つであると特定しています。また、STDや迅速パートナー療法（EPT）についての認識を高めるための様々な組織の関与の増加は、市場における相当な需要につながるでしょう。
TechNavio社は、主要なパラメーターの分析による複数のソースからのデータの調査、合成、および合計によって、市場の詳細な状況を提示します。
本レポートは以下の分野をカバーしています。
- 性感染症（STD）治療の市場規模
- 性感染症（STD）治療の市場予測
- 性感染症（STD）治療市場の業界分析
TechNavio社の堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されており、これに沿って、主要な性感染症（STD）治療市場ベンダーの詳細な分析を提供します
-
調査企業
➣ AbbVie Inc.
➣ Affymetrix
➣ Aurobindo Pharma Ltd.
➣ Becton Dickinson and Co.
➣ Bristol Myers Squibb Co.
➣ C. H. Boehringer Sohn AG and Co. KG
➣ Cepheid Inc.
➣ DiaSorin SpA
➣ Dynavax Technologies Corp.
➣ F. Hoffmann La Roche Ltd.
➣ Gilead Sciences Inc.
➣ GlaxoSmithKline Plc
➣ Hologic Inc.
➣ Inovio Pharmaceuticals Inc.
➣ Johnson and Johnson
➣ Lee's Pharmaceutical Holdings Ltd.
➣ Lupin Ltd.
➣ Merck and Co. Inc.
➣ Mylan N.V
➣ Pfizer Inc.
また、本レポートには、市場の成長に影響を与える今後の動向と課題に関する情報が含まれており、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。
この調査は、業界の主要な参加者からの情報を含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加えて、包括的な市場とベンダー情勢が含まれています。
TechNavio社について
TechNavio社は、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析により、複数のソースからのデータの調査、統合、および集計により、市場の詳細な状況を提示します。また、業界の主要なインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは、包括的で信頼性が高く、一次および二次の広範な調査の結果です。TechNavio社の市場調査レポートは、完全な競争環境と、質的および量的調査を使用して正確な市場成長を予測する詳細なベンダー選択の調査手法と分析を提供します。
レポート詳細
目次
Table of Contents
1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ billion)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ billion)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Type
5.1 Market segments
Exhibit 24: Chart on Type - Market share 2021-2026 (%)
Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
5.2 Comparison by Type
Exhibit 26: Chart on Comparison by Type
Exhibit 27: Data Table on Comparison by Type
5.3 Viral infections - Market size and forecast 2021-2026
Exhibit 28: Chart on Viral infections - Market size and forecast 2021-2026 ($ billion)
Exhibit 29: Data Table on Viral infections - Market size and forecast 2021-2026 ($ billion)
Exhibit 30: Chart on Viral infections - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Viral infections - Year-over-year growth 2021-2026 (%)
5.4 Bacterial infections - Market size and forecast 2021-2026
Exhibit 32: Chart on Bacterial infections - Market size and forecast 2021-2026 ($ billion)
Exhibit 33: Data Table on Bacterial infections - Market size and forecast 2021-2026 ($ billion)
Exhibit 34: Chart on Bacterial infections - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Bacterial infections - Year-over-year growth 2021-2026 (%)
5.5 Other infections - Market size and forecast 2021-2026
Exhibit 36: Chart on Other infections - Market size and forecast 2021-2026 ($ billion)
Exhibit 37: Data Table on Other infections - Market size and forecast 2021-2026 ($ billion)
Exhibit 38: Chart on Other infections - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Other infections - Year-over-year growth 2021-2026 (%)
5.6 Market opportunity by Type
Exhibit 40: Market opportunity by Type ($ billion)
6 Customer Landscape
6.1 Customer landscape overview
Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 44: Chart on Geographic comparison
Exhibit 45: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ billion)
Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ billion)
Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ billion)
Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ billion)
Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ billion)
Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ billion)
Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ billion)
Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ billion)
Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Japan - Market size and forecast 2021-2026
Exhibit 66: Chart on Japan - Market size and forecast 2021-2026 ($ billion)
Exhibit 67: Data Table on Japan - Market size and forecast 2021-2026 ($ billion)
Exhibit 68: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on Japan - Year-over-year growth 2021-2026 (%)
7.9 China - Market size and forecast 2021-2026
Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ billion)
Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ billion)
Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
7.10 Germany - Market size and forecast 2021-2026
Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ billion)
Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ billion)
Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.11 UK - Market size and forecast 2021-2026
Exhibit 78: Chart on UK - Market size and forecast 2021-2026 ($ billion)
Exhibit 79: Data Table on UK - Market size and forecast 2021-2026 ($ billion)
Exhibit 80: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 82: Market opportunity By Geographical Landscape ($ billion)
8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 83: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends
9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 85: Overview on factors of disruption
9.4 Industry risks
Exhibit 86: Impact of key risks on business
10 Vendor Analysis
10.1 Vendors covered
Exhibit 87: Vendors covered
10.2 Market positioning of vendors
Exhibit 88: Matrix on vendor position and classification
10.3 AbbVie Inc.
Exhibit 89: AbbVie Inc. - Overview
Exhibit 90: AbbVie Inc. - Product / Service
Exhibit 91: AbbVie Inc. - Key offerings
10.4 Aurobindo Pharma Ltd.
Exhibit 92: Aurobindo Pharma Ltd. - Overview
Exhibit 93: Aurobindo Pharma Ltd. - Product / Service
Exhibit 94: Aurobindo Pharma Ltd. - Key offerings
10.5 Bristol Myers Squibb Co.
Exhibit 95: Bristol Myers Squibb Co. - Overview
Exhibit 96: Bristol Myers Squibb Co. - Product / Service
Exhibit 97: Bristol Myers Squibb Co. - Key offerings
10.6 C. H. Boehringer Sohn AG and Co. KG
Exhibit 98: C. H. Boehringer Sohn AG and Co. KG - Overview
Exhibit 99: C. H. Boehringer Sohn AG and Co. KG - Business segments
Exhibit 100: C. H. Boehringer Sohn AG and Co. KG - Key news
Exhibit 101: C. H. Boehringer Sohn AG and Co. KG - Key offerings
Exhibit 102: C. H. Boehringer Sohn AG and Co. KG - Segment focus
10.7 Dynavax Technologies Corp.
Exhibit 103: Dynavax Technologies Corp. - Overview
Exhibit 104: Dynavax Technologies Corp. - Product / Service
Exhibit 105: Dynavax Technologies Corp. - Key news
Exhibit 106: Dynavax Technologies Corp. - Key offerings
10.8 F. Hoffmann La Roche Ltd.
Exhibit 107: F. Hoffmann La Roche Ltd. - Overview
Exhibit 108: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 109: F. Hoffmann La Roche Ltd. - Key news
Exhibit 110: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 111: F. Hoffmann La Roche Ltd. - Segment focus
10.9 Gilead Sciences Inc.
Exhibit 112: Gilead Sciences Inc. - Overview
Exhibit 113: Gilead Sciences Inc. - Product / Service
Exhibit 114: Gilead Sciences Inc. - Key news
Exhibit 115: Gilead Sciences Inc. - Key offerings
10.10 GlaxoSmithKline Plc
Exhibit 116: GlaxoSmithKline Plc - Overview
Exhibit 117: GlaxoSmithKline Plc - Business segments
Exhibit 118: GlaxoSmithKline Plc - Key news
Exhibit 119: GlaxoSmithKline Plc - Key offerings
Exhibit 120: GlaxoSmithKline Plc - Segment focus
10.11 Johnson and Johnson
Exhibit 121: Johnson and Johnson - Overview
Exhibit 122: Johnson and Johnson - Business segments
Exhibit 123: Johnson and Johnson - Key news
Exhibit 124: Johnson and Johnson - Key offerings
Exhibit 125: Johnson and Johnson - Segment focus
10.12 Merck and Co. Inc.
Exhibit 126: Merck and Co. Inc. - Overview
Exhibit 127: Merck and Co. Inc. - Business segments
Exhibit 128: Merck and Co. Inc. - Key news
Exhibit 129: Merck and Co. Inc. - Key offerings
Exhibit 130: Merck and Co. Inc. - Segment focus
11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 131: Inclusions checklist
Exhibit 132: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 133: Currency conversion rates for US$
11.4 Research methodology
Exhibit 134: Research methodology
Exhibit 135: Validation techniques employed for market sizing
Exhibit 136: Information sources
11.5 List of abbreviations
Exhibit 137: List of abbreviations
